EUVIMEDEUVIMED entdecken
Crossref

Estrogen Receptor β Activation Mitigates Colitis-associated Intestinal Fibrosis via Inhibition of TGF-β/Smad and TLR4/MyD88/NF-κB Signaling Pathways

Fangmei Ling, Yidong Chen iD, Junrong Li, Mingyang Xu, Gengqing Song iD, Lei Tu, Huan Wang, Shuang Li, Liangru Zhu iD

Inflammatory Bowel Diseases · 2025

DOI: 10.1093/ibd/izae156 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2025. Verfasst von Fangmei Ling und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Toll-Like Receptor 4, Myeloid Differentiation Factor 88, Fibrosis, Signal Transduction. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Ministry of Science and Technology of China, the Guangxi Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intestinal fibrosis, a complex complication of colitis, is characterized by excessive extracellular matrix (ECM) deposition. Estrogen receptor (ER) β may play a role in regulating this process.

Methods

Intestinal tissue samples from stenotic and nonstenotic regions were collected from Crohn’s disease (CD) patients. RNA sequencing was conducted on a mouse model to identify differentially expressed mRNAs. Histological, immunohistochemical, and semiquantitative Western blotting analyses were employed to assess ECM deposition and fibrosis. The roles of relevant pathways in fibroblast transdifferentiation, activity, and migration were examined.

Results

Estrogen receptor β expression was found to be downregulated in the stenotic intestinal tissue of CD patients. Histological fibrosis score, collagen deposition, and profibrotic molecules in the colon of an intestinal fibrosis mouse model were significantly decreased after activation of ERβ. In vitro, ERβ activation alleviated transforming growth factor (TGF)-β-induced fibroblast activation and migration, as evidenced by the inhibition of col1α1, fibronectin, α-smooth muscle actin (α-SMA), collagen I, and N-cadherin expression. RNA sequencing showed that ERβ activation affected the expression of genes involved in ECM homeostasis and tissue remodeling. Enrichment analysis of differentially expressed genes highlighted that the downregulated genes were enriched in ECM-receptor interaction, TGF-β signaling, and Toll-like receptor (TLR) signaling. Western blotting confirmed the involvement of TGF-β/Smad and TLR4/MyD88/NF-κB signaling pathways in modulating fibrosis both in vivo and in vitro. The promoter activity of TGF-β1 and TLR4 could be suppressed by ERβ transcription factor.

Conclusion

Estrogen receptor β may regulate intestinal fibrosis through modulation of the TGF-β/Smad and TLR4/MyD88/NF-κB signaling pathways. Targeting ERβ activation could be a promising therapeutic strategy for treating intestinal fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 4Myeloid Differentiation Factor 88FibrosisSignal TransductionNF-kappa BEstrogen Receptor betaTransforming Growth Factor betaColitisCrohn DiseaseAnimalsMiceHumansSmad ProteinsMice, Inbred C57BLFemaleDisease Models, AnimalMale

Stichwörter der Autor:innen

Crohn’s diseaseTGF-βTLR4estrogen receptor βintestinal fibrosis

Substanzen

Toll-Like Receptor 4Myeloid Differentiation Factor 88NF-kappa BEstrogen Receptor betaTransforming Growth Factor betaSmad ProteinsTLR4 protein, humanTlr4 protein, mouseMYD88 protein, human

Autor:innen und Institutionen

  • Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Gastroenterology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
  • Department of Gastroenterology and Hepatology, Metrohealth Medical Center, Case Western Reserve University, Cleveland, OH, USA.

ORCID-Profile: Yidong Chen, Gengqing Song, Liangru Zhu

Förderung

  • National Natural Science Foundation of China
  • Ministry of Science and Technology of China
  • the Guangxi Natural Science Foundation
  • Natural Science Foundation of Hubei Province
  • Wuhan Knowledge Innovation Special Basic Research
  • Science Research Foundation of Union Hospital
  • Teaching Reform Project of the First Clinical College

Zitieren

APA

Ling, F., Chen, Y., Li, J., Xu, M., Song, G., Tu, L., Wang, H., Li, S., & Zhu, L. (2025). Estrogen Receptor β Activation Mitigates Colitis-associated Intestinal Fibrosis via Inhibition of TGF-β/Smad and TLR4/MyD88/NF-κB Signaling Pathways. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izae156

Vancouver

Ling F, Chen Y, Li J, Xu M, Song G, Tu L, et al. Estrogen Receptor β Activation Mitigates Colitis-associated Intestinal Fibrosis via Inhibition of TGF-β/Smad and TLR4/MyD88/NF-κB Signaling Pathways. Inflammatory Bowel Diseases. 2025. doi:10.1093/ibd/izae156

BibTeX
@article{Ling2025,
  author = {Ling, Fangmei and Chen, Yidong and Li, Junrong and Xu, Mingyang and Song, Gengqing and Tu, Lei and Wang, Huan and Li, Shuang and Zhu, Liangru},
  title = {Estrogen Receptor β Activation Mitigates Colitis-associated Intestinal Fibrosis via Inhibition of TGF-β/Smad and TLR4/MyD88/NF-κB Signaling Pathways},
  journal = {Inflammatory Bowel Diseases},
  year = {2025},
  doi = {10.1093/ibd/izae156}
}
Kostenlos starten →